Cryo-Cell International Inc（CCEL）資訊與事件CCELCryo-Cell International Inc

Company Reports Q2 Revenue of $7.8M

Reports Q2 revenue $7.8M vs $7.9M last year.

Cryo-Cell Receives Acceptance of Compliance Plan from NYSE American

Cryo-Cell announced that the NYSE American has accepted the company's previously submitted plan to regain compliance with continued listing standards. As previously disclosed on March 12, the company was notified that it was not in compliance with Section 1003 (a) of the NYSE American Company Guide because the Company reported (i) a stockholders' deficit as of November 30, 2025, and (ii) net losses in two of its three most recent fiscal years ended November 30, 2023, November 30, 2024 and November 30, 2025. On April 8, the company submitted a plan to address these deficiencies. NYSE Regulation has reviewed and accepted the plan, granting Cryo-Cell a compliance period through September 9, 2027. During this time, the company's common stock will continue to be listed and traded on NYSE American, subject to ongoing review and adherence to the plan's initiatives. There can be no assurance that the company will be able to regain compliance with the NYSE American continued listing standards by the September 9, 2027, Plan Period deadline. If the company fails to regain compliance by such date or fails to make progress consistent with the accepted compliance plan during the Plan Period, the NYSE American may initiate delisting proceedings.

Company Q1 Revenue Declines to $7.68M

Reports Q1 revenue $7.68M vs. $7.97M last year. The company said, "The revenues for the first quarter of fiscal 2026 were $7.68 million compared to $7.97 million for the first quarter of fiscal 2025. The revenues for the first quarter of fiscal 2026 consisted of $7.64 million in processing and storage fee revenue, $36,000 in product revenue and approximately $1,400 in public banking revenue compared to $7.87 million in processing and storage fee revenue, $21,000 in product revenue and approximately $82,000 in public banking revenue for the first quarter of fiscal 2025. The Company reported net income of approximately $47,000 or $0.01 per basic and diluted common share for the three months ended February 28, 2026, compared to net income of approximately $283,000, or $0.03 per basic and diluted common share for the same period in 2025."